Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 217722
Company: HARM REDUCTION THERP

Products on NDA 217722

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RIVIVE	NALOXONE HYDROCHLORIDE	3MG/SPRAY	SPRAY, METERED;NASAL	Over-the-counter	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 217722

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/28/2023	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	PRIORITY	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217722Orig1s000Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217722Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/217722Orig1s000TOC.cfm

Labels for NDA 217722

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/28/2023	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217722Orig1s000Lbl.pdf

Other OTC Drugs with the Same Active Ingredient, Strength and Dosage Form/Route

RIVIVE

The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.

SPRAY, METERED;NASAL; 3MG/SPRAY

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	Application No.	Company
RIVIVE	NALOXONE HYDROCHLORIDE	3MG/SPRAY	SPRAY, METERED;NASAL	Over-the-counter	Yes	217722	HARM REDUCTION THERP